Cargando…

Comparing the clinical outcomes in patients with atrial fibrillation receiving dual antiplatelet therapy and patients receiving an addition of an anticoagulant after coronary stent implantation: A systematic review and meta-analysis of observational studies

BACKGROUND: Data regarding the clinical outcomes in patients with atrial fibrillation (AF) receiving dual antiplatelet therapy (DAPT) and an anticoagulant in addition to DAPT (DAPT + vitamin K antagonist [VKA]) after coronary stent implantation are still controversial. Therefore, in order to solve t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chaudhary, Nabin, Bundhun, Pravesh Kumar, Yan, He
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2016
Materias:	3400
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5268038/ https://www.ncbi.nlm.nih.gov/pubmed/27977592 http://dx.doi.org/10.1097/MD.0000000000005581

Ejemplares similares

Biodegradable polymer drug-eluting stents versus first-generation durable polymer drug-eluting stents: A systematic review and meta-analysis of 12 randomized controlled trials
por: Bundhun, Pravesh Kumar, et al.
Publicado: (2017)

Are Everolimus-Eluting Stents Associated With Better Clinical Outcomes Compared to Other Drug-Eluting Stents in Patients With Type 2 Diabetes Mellitus?: A Systematic Review and Meta-Analysis
por: Bundhun, Pravesh Kumar, et al.
Publicado: (2016)

Stent thrombosis and adverse cardiovascular outcomes observed between six months and five years with sirolimus-eluting stents and other drug-eluting stents in patients with Type 2 diabetes mellitus complicated by coronary artery disease: A systematic review and meta-analysis
por: Bundhun, Pravesh Kumar, et al.
Publicado: (2016)

Adverse cardiovascular events associated with biodegradable polymer drug-eluting stents and durable polymer everolimus-eluting stents: A systematic review and meta-analysis of 10 randomized controlled trials
por: Bundhun, Pravesh Kumar, et al.
Publicado: (2017)

Resuming anticoagulation in patients with atrial fibrillation experiencing intracranial hemorrhage
por: Wu, Victor Chien-Chia, et al.
Publicado: (2021)

Fatal Events in Cancer Patients Receiving Anticoagulant Therapy for Venous Thromboembolism
por: Farge, Dominique, et al.
Publicado: (2015)

Is Extended Duration of Dual Antiplatelet Therapy After Carotid Stenting Beneficial?
por: Jhang, Kai-Ming, et al.
Publicado: (2015)

Should fraction flow reserve be considered an important decision-making tool to stratify patients with stable coronary artery disease for percutaneous coronary intervention?: A meta-analysis
por: Bundhun, Pravesh Kumar, et al.
Publicado: (2017)

The safety and efficacy of oral anticoagulants with dual versus single antiplatelet therapy in patients after percutaneous coronary intervention: A meta-analysis
por: Chen, Jie, et al.
Publicado: (2017)

Outcomes of ≤6-month versus 12-month dual antiplatelet therapy after drug-eluting stent implantation: A meta-analysis and meta-regression
por: Villablanca, Pedro A., et al.
Publicado: (2016)

Impact of coronary artery bypass surgery and percutaneous coronary intervention on mortality in patients with chronic kidney disease and on dialysis: A systematic review and meta-analysis
por: Bundhun, Pravesh Kumar, et al.
Publicado: (2016)

Bleeding events associated with fibrinolytic therapy and primary percutaneous coronary intervention in patients with STEMI: A systematic review and meta-analysis of randomized controlled trials
por: Bundhun, Pravesh Kumar, et al.
Publicado: (2016)

Efficacy and Safety of Oral Anticoagulants Versus Aspirin for Patients With Atrial Fibrillation: A Meta-Analysis
por: Zhang, Jing-Tao, et al.
Publicado: (2015)

Effect of anticoagulation therapy in older patients with chronic kidney disease and atrial fibrillation: A meta-analysis
por: He, Wenfeng, et al.
Publicado: (2019)

Comparing the Clinical Outcomes Between Insulin-treated and Non-insulin-treated Patients With Type 2 Diabetes Mellitus After Coronary Artery Bypass Surgery: A Systematic Review and Meta-analysis
por: Munnee, Krishna, et al.
Publicado: (2016)

Comparing the effectiveness and safety between triple antiplatelet therapy and dual antiplatelet therapy in type 2 diabetes mellitus patients after coronary stents implantation: a systematic review and meta-analysis of randomized controlled trials
por: Bundhun, Pravesh Kumar, et al.
Publicado: (2015)

Worse clinical outcomes following percutaneous coronary intervention with a high SYNTAX score: A systematic review and meta-analysis
por: Bundhun, Pravesh Kumar, et al.
Publicado: (2017)

Efficacy and safety of dual antiplatelet therapy after percutaneous coronary drug-eluting stenting: A network meta-analysis
por: Luo, Lin, et al.
Publicado: (2022)

Bleeding events associated with a low dose (110 mg) versus a high dose (150 mg) of dabigatran in patients treated for atrial fibrillation: a systematic review and meta-analysis
por: Bundhun, Pravesh Kumar, et al.
Publicado: (2017)

Does an Obesity Paradox Really Exist After Cardiovascular Intervention?: A Systematic Review and Meta-Analysis of Randomized Controlled Trials and Observational Studies
por: Bundhun, Pravesh Kumar, et al.
Publicado: (2015)

Risks and Benefits of Dual Antiplatelet Therapy Beyond 12 Months After Coronary Stenting: A Prospective Randomized Cohort Study
por: Dadjou, Yahya, et al.
Publicado: (2016)

The role of non-vitamin K antagonist oral anticoagulants in Asian patients with atrial fibrillation: A PRISMA-compliant article
por: Liu, Xuyang, et al.
Publicado: (2020)

Impact of Antiphospholipid Syndrome and/or Systemic Lupus Erythematosus on the Long-term Adverse Cardiovascular Outcomes in Patients After Percutaneous Coronary Intervention: A Systematic Review and Meta-analysis
por: Bundhun, Pravesh Kumar, et al.
Publicado: (2016)

Impact of Modifiable Cardiovascular Risk Factors on Mortality After Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis of 100 Studies
por: Bundhun, Pravesh Kumar, et al.
Publicado: (2015)

Application of the SYNTAX score in interventional cardiology: A systematic review and meta-analysis
por: Bundhun, Pravesh Kumar, et al.
Publicado: (2017)

Meta-analysis of the efficacy and safety of non-vitamin K antagonist oral anticoagulants with warfarin in Latin American patients with atrial fibrillation
por: Su, Zhiyu, et al.
Publicado: (2020)

The impact of renal function on efficacy and safety of new oral anticoagulant in atrial fibrillation patients: A systemic review and meta-analysis
por: Gui, Yi-yue, et al.
Publicado: (2019)

Comparison of the effects of left atrial appendage closure and oral anticoagulants in preventing stroke in patients with non-valvular atrial fibrillation: A protocol for systematic review and meta-analysis
por: Yue, Deyong, et al.
Publicado: (2021)

Comparison of HAS-BLED with other risk models for predicting the bleeding risk in anticoagulated patients with atrial fibrillation: A PRISMA-compliant article
por: Zeng, Junquan, et al.
Publicado: (2020)

Long-term outcome in patients receiving permanent pacemaker implantation for atrioventricular block: Comparison of VDD and DDD pacing
por: Liao, Jo-Nan, et al.
Publicado: (2016)

Monitoring the hemostasis with rotation thromboelastometry in patients with acute STEMI on dual antiplatelet therapy: First experiences
por: Samoš, Matej, et al.
Publicado: (2017)

Dental management of patients receiving anticoagulant and/or antiplatelet treatment
por: Mingarro-de-León, Ana, et al.
Publicado: (2014)

Clinical Relevance of Anticoagulation and Dual Antiplatelet Therapy to the Outcomes of Patients With Atrial Fibrillation and Recent Percutaneous Coronary Intervention With Stent
por: De Vecchis, Renato, et al.
Publicado: (2016)

Predictors and long-term clinical outcomes of newly developed atrial fibrillation in patients with cardiac implantable electronic devices
por: Kim, Bum Sung, et al.
Publicado: (2016)

Does the CHA(2)DS(2)-VASc scale sufficiently predict the risk of left atrial appendage thrombus in patients with diagnosed atrial fibrillation treated with non-vitamin K oral anticoagulants?
por: Michalska, Anna, et al.
Publicado: (2020)

Digoxin Use and Adverse Outcomes in Patients With Atrial Fibrillation
por: Zeng, Wu-Tao, et al.
Publicado: (2016)

Oncostatin M was associated with thrombosis in patients with atrial fibrillation
por: Xie, Jun, et al.
Publicado: (2017)

Patients and Their Physician’s Perspectives About Oral Anticoagulation in Patients With Atrial Fibrillation Not Receiving an Anticoagulant
por: Cannon, Christopher P., et al.
Publicado: (2023)

Effect of drug-eluting stents on 1-year risk of new-onset atrial fibrillation in patients with acute myocardial infarction treated with percutaneous coronary intervention
por: Yu, Fa-Chang, et al.
Publicado: (2020)

It can be safe to discontinue oral anticoagulants after successful atrial fibrillation ablation: A systematic review and meta-analysis of cohort studies
por: Wang, Xiangyu, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_gd7d5fukucb7dlu6tve0bha5gc